Displaying drugs 14901 - 14925 of 15525 in total
Baloramotide
Investigational
PLX-R18
Investigational
SGN-1
SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational
Briquilimab
Briquilimab is a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit).
Investigational
Alidornase alfa
Investigational
Nemvaleukin alfa
Investigational
CLBS12
CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational
Eneboparatide
Investigational
Gresonitamab
Investigational
Vepsitamab
Investigational
Haptoglobulin 1/1 (Plasma Derived)
Investigational
KB407
Investigational
Belcesiran
Investigational
SPK-7001
Investigational
M012
Investigational
Nadunolimab
Investigational
ET-101
Investigational
MRT5005
MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Investigational
C134
C134 is a genetically engineered oncolytic herpes simplex virus expressing human cytomegalovirus (HCMV) internal repeat short 1 (IRS1).
Investigational
A-16L
Investigational
Ulviprubart
Investigational
BVX-20
Investigational
Displaying drugs 14901 - 14925 of 15525 in total